se 8:20-cv-00048-JVS-JDE Document 473 Filed 07/19/21 Page lof 168 Page ID
`#:38776
`
`CX-1461
`
`Joseph R. Re (Bar No. 134479)
`joseA.re@knobbe.com
`Stephen
`. Jensenen(Bar No. 149894)
`BenjaminA.
`leneletbogen(BarNo. 208527)
`steve.jensen@
`e.com
`Perry D. Oldham SnNo.216016)
`perry..oldham@knobbe.co
`tephen W. Larson 8arNo. 240844)
`stephen.larson@knobbe.com
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, Fourteenth Floor
`Telephone: (549) 760-0404; Facsimile: (949) 760-9502
`Adam B. Powell (Bar. No. 272725)
`adam.powell@knobbe.com
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`ben. katzenellenbogen@knobbe.com
`
`Irvine, CA 926
`
`3579 ValleyCentre Drive
`Telephone: (838) 707-4000; Facsimile: (858) 707-4001
`San Diego, CA 92130
`Attorneys for Plaintiffs,
`MASIMO CORPORATION and CERCACOR LABORATORIES,INC.
`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE CENTRAL DISTRICT OF CALIFORNIA
`
`SOUTHERN DIVISION
`
`
`woBRS
`©ScoNOON
`
`ia
`
`II
`
`12
`
`13
`
`14
`
`15
`
`16
`
`~/
`
`18
`
`19
`
`20
`
`21
`
`Case No. 8:20-cv-00048-JVS-JDE
`MASIMO CORPORATION,
`a Delaware corporation; and
`nat
`ePREMCORTABORATORIES, INC,}BECLARATIONO®ADAMB.4,
`a Delaware corporation
`4
`2
`é
`FOR RECONSIDERATION OF THE
`Plaintiffs
`COURT’S JUNE 10 ORDER
`~2
`DENYING MOTION TO COMPEL
`DISCOVERY FROM TIM COOK
`(DKT. 455)
`[Di
`
`v.
`APPLE INC., a California corporation
`
`Defendant.
`
`iscovery Document: Referred to
`agistrate Judge John D. Early]
`
`Date: August 19, 2021
`Time:
`10:00 a.m.
`Ctrm:
`6A
`
`Discovery Cut-Off:
`Pre-Trial Conference:
`Trial:
`
`3/7/2022
`
`11/21/2022
`12/6/2022
`
`
`
`23
`
`24
`
`26
`
`27
`
`28
`
`PAGE 1 OF 7
`
`MASITC_01060862
`
`MASIMO2021
`Apple v. Masimo
`IPR2022-01291
`
`MASIMO 2021
`Apple v. Masimo
`IPR2022-01291
`
`

`

`Case 8:20-cv-00048-JVS-JDE Document 473 Filed 07/19/21 Page 84 o0f168 Page ID
`#:38859
`
`CX-1461
`
`EXHIBIT 6
`
`PAGE 2 OF 7
`
`MASITC_01060863
`
`MASIMO2021
`Apple v. Masimo
`IPR2022-01291
`
`MASIMO 2021
`Apple v. Masimo
`IPR2022-01291
`
`

`

`Case 8:20-cv-00048-JVS-JDE Document 473 Filed 07/19/21 Page 85 of 168
`#:38860
`
`Page ID
`
`8:18-cv-O2001-JVS-JDE Document 321-1 Filed 07/02/21 Page1of94 Page ID
`#18216
`
`Mark D. Kachner (Bar No. 234192)
`mark.kachner@knobbe.com
`KNOBBE, MARTENS, OLSON
`& BEAR, LLP
`1925 Century Park East, Suite 600
`Los Angeles, CA 90067 Telephone:
`(310) 551-3450 Facsimile: (310)
`601-1263
`
`Joseph R. Re (Bar No. 134479)
`
`ioseph re@knobbe.com
`Stephen C. Jensen (Bar No. 149894)
`stephen.jensen@knobbe.com Irfan
`Irfan A. Lateef (Bar No. 204004)
`iwfan lateef@knobbe.com
`Perry D. Oldham(Bar No. 216016)
`
`perry.oldham@knobbe.com
`Brian C. Claassen (Bar No. 253627)
`brian.claassen@knobbe.com
`KNOBBE, MARTENS, OLSON
`& BEAR, LLP
`2040 Main Street, Fourteenth Floor
`Irvine, CA 92614
`Telephone: (949) 760-0404
`Facsimile: (949) 760-9502
`
`Attorneys for Plaintiffs,
`Masimo Corporation and
`Cercacor Laboratories, Inc.
`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE CENTRAL DISTRICT OF CALIFORNIA
`
`SOUTHERN DIVISION MASIMO CORPORATION,a
`
`
`
`Delaware corporation; and
`CERCACOR LABORATORIES,INC.,
`a Delaware corporation,
`
`Plaintiffs/Counterdefendants,
`
`Vv.
`
`TRUE WEARABLES, INC., a
`Delaware corporation; and
`MARCELO LAMEGO, anindividual,
`
`Defendants/Counterclaimants.
`
`Case No. 8:18-CV-02001-JVS-IDE
`
`PLAINTIFFS’ EXHIBITS3-5, 8,
`AND 10 TO THE
`DECLARATION OF MARK D.
`KACHNER IN SUPPORT OF
`OPPOSITION TO APPLE INC’S
`MOTION TO QUASH AND FOR
`A PROTECTIVE ORDER
`
`Hon. James V. Selna
`Hon. Magistrate John D. Early
`
`[Discovery Document: Referred to
`Magistrate Judge John D. Early]
`
`Hearing: June 24, 2021
`Time: 10:00 a.m.
`Court: Room: 6A
`
`UNREDACTED VERSION OF DOCUMENTS FILED PURSUANT TO ORDER OF THE
`
`COURT DATED JUNE24, 2021 (DKT. NO. 311)
`
`Case
`
`20
`
`21
`
`22
`
`23
`
`24
`
`26
`
`27
`
`28
`
` CX-1461
`
`PAGE 3 OF 7
`
`Exhibit 6
`
`-/8-
`
`MASITC_01060864
`
`MASIMO2021
`Apple v. Masimo
`IPR2022-01291
`
`MASIMO 2021
`Apple v. Masimo
`IPR2022-01291
`
`

`

`Case 8:20-cv-00048-JVS-JDE Document 473 Filed 07/19/21 Page 86 0f168 Page ID
`#:38861
`Case 8:18-cv-02001-JVS-JDE Document 321-1 Filed 07/02/21 Page 36o0f94 Page ID
`#:18251
`
`CX-1461
`
`EXHIBIT 4
`
`[TRUE016520-522]
`
`-35-
`
`PAGE 4 OF 7
`
`Exhibit 6
`
`-79-
`
`MASITC_01060865
`
`MASIMO2021
`Apple v. Masimo
`IPR2022-01291
`
`MASIMO 2021
`Apple v. Masimo
`IPR2022-01291
`
`

`

`Case 8:20-cv-00048-JVS-JDE Document 473 Filed 07/19/21 Page 87 of 168 Page ID
`#:38862
`
`stantord aren’ SeoSR,AESGy02001-JVS-JDE Poeunea Filed 07/02/21 Page 37 of 94 Page ID
`
`VWA418, 130 AM
`
`CX-1461
`
`
`
`The three equations
`
`Marcelo Lamriedo <mrniamego@stanfordalumnLorg>
`‘To! teook@apple.com
`
`Dear Tim Cook,
`
`Weed, Got 2, 2043 at 12:54 AM
`
`| was approached by Apple in the beginning of this year (by David Affourtit and James Foster)
`and was asked if | would like to join the executive technical team. Because | did not want to sign
`the Apple's NDA for an onsite interview, the process came to a halt. | felt that it was not
`appropriate to receive confidential information fram or disclose confidential information to Apple
`given my liduciary responsibilities as the Chief Technical Officer of Cercarcor.
`
`| have developed several medical devices in the last 10 years and | am positively sure | could
`acd a significant value to the Apple team, if | was given the chance of becoming pari of it ina
`senior technical executive position and without conflicting with the large IP | have developed for
`Masime and Cercaceor during the same period.
`
`What | am sure Apple soon will realize is that medical, wellness and fitness technologies are
`very deceptive in the sense thal they are easy to develop for products that work in mast (~80%)
`he users, Getting the same technology to work in almost the entire population is a problem
`extremely more complex. This is the very reason most medical device startups become
`insolvent. Knowing Appie’s reputation, | am sure you would not settle for even 99%, imagine
`then, 80%.
`
`AS you probably know, regulatory barriers are another important consideration when dealing
`with medical technologies in general. If the FDA or any other regulatory agency worldwide (.e.,
`Canada, Japan, Korea, Europe, etc.) believe your product should be regulated by their
`standards then, the choice of intended use combined with the technology realization strategy
`can Make the development shorten or longer by several years.
`
`The reason| feel attracted by Appie as a company is not related to the things most people are
`interested in, .e., brand recognition, great culture, great products, great people. it has to do
`with the fact that, as an engineer, | realized that there are three important equationsto be
`solved in order to create a competitive global medical, wellness and fitness product portfalio:
`() The user equation - Apple has solved it and created the industry standard. With a brand
`recognition similar to the ones from luxury products, everybody Is interested in understanding
`and using Apple's intuitive interfaces.
`
`(i) The patient equation - This is the deceptive part.
`
`“The connectivity equation - This can only be solved with scale and brand recognition, which
`é synonymousfor Apple. Reliable wireless technology and device interoperability will become
`amust in the medical device segment.
`
`hitpsy//real googhh.cont /nieilfu/OtikedOB2ddeWSeaview=pi&iguarah=:.Amag-PGBat4ds 7 PEGRE ALES PAT ASSinipi=mag-f eSAld aT7EG SH20894 741 28
`
`Page Tat?
`
`EXHIBIT4
`
`PAGE 5 OF 7
`
`Exhibit 6
`-80-
`
`MASITC_01060866
`
`MASIMO2021
`Apple v. Masimo
`
`MASIMO 2021
`Apple v. Masimo
`IPR2022-01291
`
`

`

`CX-1461
`
`Case 8:20-cv-00048-JVS-JDE Document 473 Filed 07/19/21 Page 88 of 168 Page ID
`#:38863
`
`Case 8:18-cv-02001-JVS-JDE Document32t-i Filed 07/02/21 Page 38 of 94 PageID
`Staivfard Aturini Mail - The three équatians
`VER4HE, PESO AM
`
`| can helo you to solve 4
`| believe Appie has solved (i) and has encugh resourcesto solve (iil).
`|
`“suld appreciate f the content of this letter could be kept confidential, since ft can jeopardize
`« Ouicome of my career at Cercacor.
`
`i strongly believe that we can develop the new wave of technology that will make Apple the
`number one brand in the medical, fitness and wellness device market. If you agree, feel free to
`contact me enylime.
`
`Adlihe best,
`
`Marcelo Malini Lamego
`
`18 Lyra Way
`
`Coto de Caza CA 92879
`
`Home phone: (849) 216-9204
`
`My resume is available at Ails sweAnkedin car
`
`Confidentiality noting. This e-mail may contain information. confidential and/or privileged fromdisclosure. if the
`reader is not the Intended recipient, copying, dissemination or continued possession of this communicationis strictly
`prohibited.
`
`Hapsyiaailgoogle comfmalip/O?ik= AGOsdde? he Aviewsptisear ch = 16-1SAMAT 799 28224 STATSAsineMmsG- PES ATG4 2 BUGS P24 BISTTS
`
`Page 2 of-2
`
`Po
`
`EXHIBIT4
`
`-37-
`
`PAGE 6 OF 7
`
`TRUEO16521
`
`Exhibit 6
`-81-
`
`MASITC_01060867
`
`MASIMO2021
`Apple v. Masimo
`
`MASIMO 2021
`Apple v. Masimo
`IPR2022-01291
`
`

`

`Case 8:20-cv-00048-JVS-JDE Document 473 Filed 07/19/21 Page 89 of 168 Page ID
`#:38864
`
`_ ASE 8:18-cv-02001-JVS-JDE Document 321-1 Filed 07/02/21 Page 39 of 94 Page ID
`7
`Stantarc Atumn!
`Mad - Aopte
`#182954
`PZENB, 3:09 PM
`
`CX-1461
`
`
`
`David Affourtht <affourli@appie.com>
`Yo: Marcelo Larnega <mmiameqo@stanfordalumni org>
`Ce: Denby Frazier <denby@apple.com>
`
`Hella Marcelo,
`
`Wed, Oct 2, 2012 af 10:25 AM
`
`Thank you for your voicemail and follow up.
`Anple.
`
`| saw your note to Tim Cook.
`
`Im glad you remain enthusiastic about
`
`As l'ye transitioned out of the Exes Recruiting tearn into a management role, I've asked my associate from the Exec
`Recruiting team te reach oul to you directly. Her narte is Denby Frazier, ce'd.
`
`Denby, meet Marcelc, Marceba, Denby.
`
`All the best and thanks again!
`
`Cheers,
`Dave
`
`Hitps. (rel qoegic.camsmallAyO7ik=40 b2dde 25 elviewsptSacach.msg $MBAATERISOTEd B2G9.504Belnigi= may -fSSA14H 7BOD8O1 BER 2G OHO
`
`Page tot
`
`Fr
`
`EXHIBIT4
`-38-
`
`PAGE 7 OF 7
`
`TRUEO18522
`Exhibit 6
`-89-
`
`MASITC_01060868
`
`MASIMO2021
`Apple v. Masimo
`
`MASIMO 2021
`Apple v. Masimo
`IPR2022-01291
`
`